GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus

Pilar Miralles; José Tomás Navarro; Juan Berenguer; José Gómez Codina; Mi Kwon; David Serrano; José Luis Díez-Martín; Salvador Villà; Rafael Rubio; Javier Menárguez; José María Ribera Santasusana

doi:10.1016/j.medcli.2017.11.037

GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus

Pilar Miralles, José Tomás Navarro, Juan Berenguer, José Gómez Codina, Mi Kwon, David Serrano, José Luis Díez-Martín, Salvador Villà, Rafael Rubio, Javier Menárguez, José María Ribera Santasusana

Department of Medicine

Research output: Contribution to journal › Article › Research › peer-review

1 Citation (Scopus)

Abstract

© 2017 Elsevier España, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.

Original language	English
Pages (from-to)	39.e1-39.e17
Journal	Medicina Clinica
Volume	151
Issue number	1
DOIs	https://doi.org/10.1016/j.medcli.2017.11.037
Publication status	Published - 13 Jul 2018

Keywords

AIDS
Antiretroviral therapy
HIV
Hodgkin's lymphoma
Non-Hodgkin's lymphoma

Access to Document

10.1016/j.medcli.2017.11.037

Fingerprint Dive into the research topics of 'GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus'. Together they form a unique fingerprint.

Cite this

Miralles, P., Navarro, J. T., Berenguer, J., Gómez Codina, J., Kwon, M., Serrano, D., Díez-Martín, J. L., Villà, S., Rubio, R., Menárguez, J., & Ribera Santasusana, J. M. (2018). GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. Medicina Clinica, 151(1), 39.e1-39.e17. https://doi.org/10.1016/j.medcli.2017.11.037

Miralles, Pilar ; Navarro, José Tomás ; Berenguer, Juan ; Gómez Codina, José ; Kwon, Mi ; Serrano, David ; Díez-Martín, José Luis ; Villà, Salvador ; Rubio, Rafael ; Menárguez, Javier ; Ribera Santasusana, José María. / GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. In: Medicina Clinica. 2018 ; Vol. 151, No. 1. pp. 39.e1-39.e17.

@article{9c2d6b1a5adf4a208250fad119cc652c,

title = "GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus",

abstract = "{\textcopyright} 2017 Elsevier Espa{\~n}a, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.",

keywords = "AIDS, Antiretroviral therapy, HIV, Hodgkin's lymphoma, Non-Hodgkin's lymphoma",

author = "Pilar Miralles and Navarro, {Jos{\'e} Tom{\'a}s} and Juan Berenguer and {G{\'o}mez Codina}, Jos{\'e} and Mi Kwon and David Serrano and D{\'i}ez-Mart{\'i}n, {Jos{\'e} Luis} and Salvador Vill{\`a} and Rafael Rubio and Javier Men{\'a}rguez and {Ribera Santasusana}, {Jos{\'e} Mar{\'i}a}",

year = "2018",

month = jul,

day = "13",

doi = "10.1016/j.medcli.2017.11.037",

language = "English",

volume = "151",

pages = "39.e1--39.e17",

number = "1",

}

Miralles, P, Navarro, JT, Berenguer, J, Gómez Codina, J, Kwon, M, Serrano, D, Díez-Martín, JL, Villà, S, Rubio, R, Menárguez, J & Ribera Santasusana, JM 2018, 'GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus', Medicina Clinica, vol. 151, no. 1, pp. 39.e1-39.e17. https://doi.org/10.1016/j.medcli.2017.11.037

GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus. / Miralles, Pilar; Navarro, José Tomás; Berenguer, Juan; Gómez Codina, José; Kwon, Mi; Serrano, David; Díez-Martín, José Luis; Villà, Salvador; Rubio, Rafael; Menárguez, Javier; Ribera Santasusana, José María.

In: Medicina Clinica, Vol. 151, No. 1, 13.07.2018, p. 39.e1-39.e17.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus

AU - Miralles, Pilar

AU - Navarro, José Tomás

AU - Berenguer, Juan

AU - Gómez Codina, José

AU - Kwon, Mi

AU - Serrano, David

AU - Díez-Martín, José Luis

AU - Villà, Salvador

AU - Rubio, Rafael

AU - Menárguez, Javier

AU - Ribera Santasusana, José María

PY - 2018/7/13

Y1 - 2018/7/13

N2 - © 2017 Elsevier España, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.

AB - © 2017 Elsevier España, S.L.U. The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. However, differentiating characteristics of seropositive patients, such as the need for cART and specific prophylaxis and treatment of certain opportunistic infections, should be considered. This document updates recommendations on the diagnosis and treatment of lymphomas in HIV infected patients published by GESIDA/PETHEMA in 2008.

KW - AIDS

KW - Antiretroviral therapy

KW - HIV

KW - Hodgkin's lymphoma

KW - Non-Hodgkin's lymphoma

U2 - 10.1016/j.medcli.2017.11.037

DO - 10.1016/j.medcli.2017.11.037

M3 - Article

VL - 151

SP - 39.e1-39.e17

IS - 1

ER -